National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 74740-74741 [2020-25802]
Download as PDF
<![CDATA[
74740
Federal Register / Vol. 85, No. 226 / Monday, November 23, 2020 / Notices
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; DEACompliant Drug Detection and Deactivation
Technology to Deter Opioid Theft in
Hospitals for Next Generation Controlled
Substance Diversion Prevention Program
(CSDPP)
Date: December 15, 2020.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25800 Filed 11–20–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
VerDate Sep<11>2014
17:07 Nov 20, 2020
Jkt 253001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Preclinical and
Translational Vaccine Development Support
for HIV and Other Candidate Agents (PTVDS)
(N01), Task Areas C and D.
Date: December 17, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Cynthia L. De La Fuente,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25798 Filed 11–20–20; 8:45 am]
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Cynthia L. De La Fuente,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25799 Filed 11–20–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Preclinical and
Translational Vaccine Development Support
for HIV and Other Candidate Agents
(PTVDS), Task Areas A and B.
Date: December 14, 2020.
Time: 10:00 a.m. to 6:00 p.m.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: December 16, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G60,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Gregory P. Jarosik, Ph.D.
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G60, Rockville, MD 20852, (240) 669–5080,
gjarosik@niaid.nih.gov.
E:\FR\FM\23NON1.SGM
23NON1
74741
Federal Register / Vol. 85, No. 226 / Monday, November 23, 2020 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25802 Filed 11–20–20; 8:45 am]
BILLING CODE 4140–01–P
Background and Purpose
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2010–1066]
Recreational Boating Safety Projects,
Programs, and Activities Funded
Under Provisions of the Fixing
America’s Surface Transportation Act;
Fiscal Year 2020
ACTION:
published annually in the Federal
Register. This notice specifies the
funding amounts the Coast Guard has
committed, obligated, or expended
during fiscal year 2020, as of September
30, 2020.
FOR FURTHER INFORMATION CONTACT: For
questions on this notice please contact
Mr. Jeff Decker, U.S. Coast Guard,
Regulations Development Manager,
(202) 372–1507 or: RBSInfo@uscg.mil.
SUPPLEMENTARY INFORMATION:
Notice.
The Coast Guard is publishing
this notice to satisfy a requirement of
the Fixing America’s Surface
Transportation Act that requires a
detailed accounting of the projects,
programs, and activities funded under
the national recreational boating safety
program provision of the Act be
SUMMARY:
Since 1998, Congress has passed a
series of laws providing funding for
projects, programs, and activities
funded under the national recreational
boating safety program, which is
administered by the U.S. Coast Guard.
For a detailed description of the
legislative history, please see the
Recreational Boating Safety Projects,
Programs, and Activities Funded Under
Provisions of the Fixing America’s
Surface Transportation Act; Fiscal Year
2016 Notice published in the Federal
Register on April 12, 2017 (82 FR
17671).
These funds are available to the
Secretary from the Sport Fish
Restoration and Boating Trust Fund
(Trust Fund) established under 26
U.S.C. 9504(a) for payment of Coast
Guard expenses for personnel and
activities directly related to
coordinating and carrying out the
national recreational boating safety
program. Amounts made available
under this subsection remain available
during the two succeeding fiscal years.
Any amount that is unexpended or
unobligated at the end of the 3-year
period during which it is available shall
be withdrawn by the Secretary and
allocated to the States in addition to any
other amounts available for allocation in
the fiscal year in which they are
withdrawn or the following fiscal year.
Use of these funds requires
compliance with standard Federal
contracting rules with associated lead
and processing times resulting in a lag
time between available funds and
spending. The total amount of funding
transferred to the Coast Guard from the
Trust Fund, and committed, obligated,
and/or expended during fiscal year 2020
for each project is shown below.
Specific Accounting of Funds
The total amount of funding
transferred to the Coast Guard from the
Sport Fish Restoration and Boating
Trust Fund and committed, obligated,
and/or expended during fiscal year 2020
for each project is shown in the chart
below.
Project
Description
46 USC 43 Compliance: Inspection Program/Boat Testing Program.
46 USC 43 Compliance: Staff Salaries
and Travel.
Administrative Overhead ..........................
Boating Accident Report Database
(BARD) Web System.
Provided for continuance of the national recreational boat compliance inspection
program, which began in January 2001.
Provided for personnel to oversee manufacturer compliance with 46 U.S.C. 43 requirements.
Supplies and Materials to support the RBS Program .................................................
Provided for maintaining the BARD Web System, which enables reporting authorities in the 50 States, five U.S. Territories, and the District of Columbia to submit
their accident reports electronically over a secure Internet connection.
Provided contract personnel to conduct boating safety-related research and analysis.
Provided to facilitate staff training on new grant management requirements .............
Provided for travel by employees of the Boating Safety Division to gather background and planning information for new recreational boating safety initiatives.
Provided for 18 personnel directly related to coordinating and carrying out the national recreational boating safety program and Administrative Reserve Support.
Provided for collecting data to support the National Recreational Boating Survey ....
Contract Personnel Support .....................
Grant Management Training .....................
Recreational Boating Safety Program
Travel.
Reimbursable Salaries ..............................
Survey .......................................................
Of the $8.307 million made available
to the Coast Guard in fiscal year 2020,
$709,802 has been committed,
obligated, or expended and an
additional $6,289,226 of prior fiscal year
funds have been committed, obligated,
or expended, as of September 30, 2020.
The remainder of the FY19 and FY20
funds made available to the Coast Guard
(approximately $9.231 million) may be
retained for the allowable period for the
National Recreational Boating Survey,
the expected reengineering of the
Boating Accident and Reporting
VerDate Sep<11>2014
17:07 Nov 20, 2020
Jkt 253001
Database, and other projects, or it may
be transferred into the pool of money
available for allocation through the state
grant program.
Authority
This notice is issued pursuant to 5
U.S.C. 552 and 46 U.S.C. 13107(c)(4).
Dated: November 17, 2020.
Wayne R. Arguin, Jr.,
Captain, U.S. Coast Guard, Director of
Inspections and Compliance.
[FR Doc. 2020–25775 Filed 11–20–20; 8:45 am]
BILLING CODE 9110–04–P
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Cost
$2,041,346
560,150
37,506
514,186
924,254
96,501
41,433
2,733,653
50,000
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0048]
Agency Information Collection
Activities: Declaration of Person Who
Performed Repairs or Alterations
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
AGENCY:
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 85, Number 226 (Monday, November 23, 2020)]
[Notices]
[Pages 74740-74741]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel NIAID Investigator Initiated Program
Project Applications (P01 Clinical Trial Not Allowed).
Date: December 16, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G60,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Gregory P. Jarosik, Ph.D. Scientific Review
Program, Division of Extramural Activities, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G60, Rockville, MD 20852, (240) 669-5080,
[email protected].
[[Page 74741]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 17, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-25802 Filed 11-20-20; 8:45 am]
BILLING CODE 4140-01-P
